Ignite Creation Date:
2024-05-06 @ 12:28 PM
Last Modification Date:
2024-10-26 @ 12:59 PM
Study NCT ID:
NCT03761914
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2022-02-21
First Post:
2018-11-28
Brief Title:
Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers
Sponsor:
Organization:
Sellas Life Sciences Group